Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

News > All

Total search results: 9799 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 55 56 57 ... 96 97 98  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Hookipa Biotech AG. (11/4/13). "Press Release: Hookipa Biotech Closes €20 Million ($27.5 Million) in Series B Financing. Funds to Be Used to Progress Viral Vaccine Pipeline and to Explore Applications in Cancer Immunotherapy". Vienna. 2013-11-04
Formycon AG. (11/4/13). "Press Release: Formycon AG Today Has Announced the Appointment of Gerhard Schaefer and Simon Sturge to Formycon’s Advisory Board". Munich. 2013-11-04
Utrecht University. (11/4/13). "Press Release: Alexander Makarov Appointed as Professor of High Resolution Mass Spectrometry. Strengthening of Collaboration with Thermo Fisher Scientific". 2013-11-04
Kadimastem Ltd.. (11/4/13). "Press Release: Merck Serono and Kadimastem Sign Memorandum of Understanding (MOU) on Drug Screening and Discovery for Neurodegenerative Diseases". Nes Ziona & Darmstadt. 2013-11-04
Actelion Ltd.. (11/4/13). "Press Release: Actelion Announces U.S. Commercial Availability of Opsumit (macitentan) as of November 4". South San Francisco, CA. 2013-11-04
CureVac GmbH. (11/4/13). "Press Release: CureVac Collaborates with the Cancer Research Institute and Ludwig Cancer Research to Enalbe Clinical Testing of Novel Immunotherapy Treatment Options for Cancer". Tübingen & New York, NY. 2013-11-04
Roche. (11/4/13). "Press Release: Roche and Polyphor Join Efforts to Combat Multi-drug-resistant Bacterial Infections". Basel. 2013-11-04
Bruker Corporation. (11/1/13). "Press Release: Bruker Corporation Reports Third Quarter 2013 Financial Results". Billerica, MA. 2013-11-01
Biognosys AG. (11/1/13). "Press Release: New Release of iRT Kit". 2013-11-01
Anton Paar GmbH. (11/13). "Press Release: Anton Paar GmbH Acquires CSM Instruments SA". 2013-11-01
BASF SE. (10/31/13). "Press Release: BASF Successfully Completes Verenium Tender Offer. Cash Tender Offer of US$4.00 per Share Successful – Approximately 71% of Verenum’s Shares Tendered". Ludwigshafen. 2013-10-31
Merck Serono. (10/31/13). "Press Release: Merck Serono Announces Five-year Strategic Partnership with the Lead Disovery Center". Darmstadt. 2013-10-31
Genedata AG. (10/30/13). "Press Release: Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support". Basel. 2013-10-30
SCiLS GmbH. (10/30/13). "Press Release: Carl Evertsz Appointed as Chairman of the SCiLS Advisory Board". Bremen. 2013-10-30
Paion AG. (10/30/13). "Press Release: Paion Grants License to R-Pharm for Remimazolam". Aachen. 2013-10-30
Curetis AG. (10/30/13). "Press Release: Curetis Receives Clearance for Unyvero System and Pneumonia Application in Russia and Serbia". Holzgerlingen. 2013-10-30
Stratec Biomedical AG. (10/30/13). "Press Release: Stratec Reports on First Nine Months of 2013". Birkenfeld. 2013-10-30
Bicoll GmbH. (10/29/13). "Press Release: Bicoll Receives Payment as Member of the €11.5 Million EU Funded EpimiRNA Project to Develop Novel Epilepsy Therapeutics". 2013-10-29
ETH Zürich. (10/29/13). "Press Release: An Artificial Enzyme that Promotes 700 Reactions per Second". 2013-10-29
Qiagen GmbH. (10/29/13). "Press Release: Qiagen Reports Third Quarter 2013 Results". Venlo. 2013-10-29
Tecan Group Ltd.. (10/29/13). "Press Release: Tecan’s AC Extraction Plate Provides a Unique Sample Preparation Tool for LC-MS". Männedorf. 2013-10-29
Epigenomics AG. (10/28/13). "Press Release: Epigenomics and BioChain Enter into Broad Strategic Collaboration in China and Investment into Epigenomics". Berlin, Newark, CA & Beijing. 2013-10-28
Paion AG. (10/28/13). "Press Release: Paion AG Grants License to Hana Pharm for Remimazolam in South Korea". Aachen. 2013-10-28
Sygnis AG. (10/28/13). "Press Release: Sygnis AG Successfully Completes Rights Offering and Private Placement". Heidelberg. 2013-10-28
Evotec AG. (10/28/13). "Press Release: Evotec Achieves First Milestones in Multi-target Deal with UCB". Hamburg. 2013-10-28
Definiens AG. (10/28/13). "Press Release: Definiens Expands Management Team to Develop the Clinical Market". 2013-10-28
Biognosys AG. (10/25/13). "Press Release: SWATH Enabling Software Spectronaut Referenced in Recent Publications". 2013-10-25
Biotest AG. (10/24/13). "Press Release: Biotest AG Successfully Placed a Schuldschein of EUR 210 m". Dreieich. 2013-10-24
Franz Haniel & Cie. GmbH. (10/24/13). "Press Release: Haniel Sells Its Entire Stake to McKesson Corporation. EUR 23.00 per Share, Takeover Premium of 39%". 2013-10-24
Basilea Pharmaceutica Ltd.. (10/23/13). "Press Release: Basilea’s Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia". Basel. 2013-10-23
Apeptico Forschung und Entwicklung GmbH. (10/23/13). "Press Release: Apeptico Announces a Licensing Agreement for Pepbase with Chem Tech Research Incorporation (C-TRI)". Vienna. 2013-10-23
Mologen AG. (10/23/13). "Press Release: Approval for Phase I Study with MGN1703 in the U.S. Obtained". 2013-10-23
GlycoUniverse GmbH & Co. KG. (10/23/13). "Press Release: Sugar Is Life – GlycoUniverse Successfully Launched at Biotechpark Berlin-Buch". Berlin. 2013-10-23
McKesson Corporation. (10/23/13). "Press Release: McKesson Announces Agreement to Purchase Celesio to Create Leading Global Healthcare Services Platform". San Francisco, CA & Stuttgart. 2013-10-23
Thermo Fisher Scientific Inc.. (10/23/13). "Press Release: University of Salzburg, Sandoz and Thermo Fisher Scientific Collaborate at New Biosimilar Characterization R&D Facility". Salzburg. 2013-10-23
Biobase GmbH. (10/23/13). "Press Release: Biobase Launches PharmacoGenomic Mutation Database (PGMD) – a Knowldege-base Containing Genetic Variants that Affect Drug Response". Beverly, MA. 2013-10-23
Siemens AG. (10/23/13). "Press Release: New Siemens HIV Combo Assay Provides Quick and Reliable Results". Tarrytown, NY. 2013-10-23
F-Star Biotechnologische Forschungs- und Entwicklungsges. m.b.H.. (10/23/13). "Press Release: F-Star Announces Formation of New Asset-centric Vehicle, F-Star Alpha Ltd, with €9.4m Series A Investment. F-Star Alpha to License Oncology and Immune-oncology 2013-10-23
Biocartis S.A.. (10/22/13). "Press Release: Biocartis Presents the Successful Use of Idylla for the Detection of BRAF Mutation Status in Tumour Samples at the International AACR Congress in Boston". Mechelen & Lausanne. 2013-10-22
Curetis AG. (10/22/13). "Press Release: Curetis Presents First Data on Novel Unyvero i60 ITI Application for Implant and Tissue Infections". Holzgerlingen. 2013-10-22
Finox AG (Finox Biotech). (10/22/13). "Press Release: Finox Biotech Shareholders Agree Capital Increase". Burgdorf. 2013-10-22
MorphoSys AG. (10/22/13). "Press Release: MorphoSys Strenghtens Patent Position on anti-CD19 Cancer Program MOR208". 2013-10-22
Novartis AG. (10/22/13). "Press Release: Novartis Delivers Strong Sales Performance in Third Quarter Driven by Growth Products’ Momentum – Innovation Newsflow Reinforces Growth Prospects". Basel. 2013-10-22
Samsung BioLogics. (10/22/13). "Press Release: Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche". Seoul. 2013-10-22
Peak Scientific Instruments Ltd.. (10/22/13). "Press Release: Peak Scientific Sign Formal OEM Agreement with Bruker’s Chemical and Applied Markets Division". 2013-10-22
Tecan Group Ltd.. (10/22/13). "Press Release: Enhancing Clinical Diagnostics with Tecan’s Cavro OmniRobot". Männedorf. 2013-10-22
Beactica AB. (10/22/13). "Press Release: Beactica Expands Its Drug Discovery Collaboration with Boehringer Ingelheim". Uppsala. 2013-10-22
Biofrontera AG. (10/21/13). "Press Release: Allergan Launches Ameluz in Spain". Leverkusen. 2013-10-21
Evonik Industries AG. (10/21/13). "Press Release: Evonik Opens a New Plant in Argentina for Catalysts Used in Biodiesel Production". Essen. 2013-10-21
Evotec AG. (10/21/13). "Press Release: Evotec Enters Integrated Alliance with AstraZeneca in Kidney Disease". Hamburg. 2013-10-21
Ganymed Pharmaceuticals AG. (10/21/13). "Press Release: Ganymed’s IMAB362 Receives Orphan Drug Designation from FDA and EMA for Pancreatic Cancer". Mainz. 2013-10-21
Qiagen N.V.. (10/21/13). "Press Release: Qiagen Announces Partnership with Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-resistant EGFR Mutations". Germantown, MD & Hilden. 2013-10-21
Sartorius AG. (10/21/13). "Press Release: Nine-Month Figures for 2013. Sartorius with Gains in Order Intake, Sales Revenue and Earnings". Göttingen. 2013-10-21
Sartorius AG. (10/21/13). "Press Release: Nine-Month Figures 2013. Sartorius Stedim Biotech on Track Towards Reaching Its 2013 Targets". 2013-10-21
University of Salzburg. (10/21/13). "Press Release: On the Test Bench. Protein-based Drugs". Salzburg. 2013-10-21
Biognosys AG. (10/18/13). "Press Release: US Patent Awarded to Biognosys". 2013-10-18
Mologen AG. (10/18/13). "Press Release: Clinical Study with MGN1404 in Malignant Melanoma Initiated. Phase I Trial to Evaluate Safety and Tolerability". 2013-10-18
Neovacs S.A.. (10/18/13). "Press Release: Miguel Sieler, former Chairman and CEO Bayer France, Named CEO of Neovacs". Paris. 2013-10-18
Actelion Ltd.. (10/18/13). "Press Release: Actelion Receives US FDA Approval for Opsumit (macitentan) for the Treatment of Pulmonary Arterial Hypertension". Allschwil. 2013-10-18
Actelion Ltd.. (10/17/13). "Press Release: Actelion on Track to Deliver Double Digit LC Core Earnings Growth". Allschwil. 2013-10-17
Biocartis S.A.. (10/17/13). "Press Release: Biocartis and Hospital del Mar Join Forces to Develop Diagnostic Colon Cancer Test". Lausanne, Mechelen & Barcelona. 2013-10-17
Biodesy, Inc.. (10/17/13). "Press Release: Biodesy Inc. Completes $15.0 Million Series A Financing and Appoints Greg Yap as Chief Executive Officer. Series A Investors include 5AM Ventures, Pfizer Venture Investments and Roche Venture". Burlingame, CA. 2013-10-17
LISAvienna. (10/17/13). "Press Release: Current Study on Life Sciences in Vienna. More than 35,000 Employees in Companies and Research Institutions". Vienna. 2013-10-17
BASF SE. (10/17/13). "Press Release: BASF Inaugurates New Facility for Plant Biotechnology Research in Ghent, Belgium. BASF Subsidiary CropDesign Moves into a New Building in Technologiepark". Ludwigshafen & Ghent. 2013-10-17
Roche. (10/17/13). "Press Release: Roche Posts Strong Sales Growth in the First Nine Months of 2013". Basel. 2013-10-17
Sygnature Discovery Ltd.. (10/17/13). "Press Release: Sygnature Discovery and Proteros Biostructures Establish Strategic Alliance". Nottingham & Munich. 2013-10-17
Certara. (10/17/13). "Press Release: Boehringer Ingelheim Selects Certara’s D360 as Its Global Drug Discovery Platform". St. Louis, MO. 2013-10-17
Firefly BioWorks. (10/16/13). "Press Release: Firefly BioWorks Announces Strategic Partnership with EMD Millipore". Cambridge, MA. 2013-10-16
Glycotope GmbH. (10/16/13). "Press Release: Glycotope Reported Promising First-in-Man Data of Novel Glycooptimized Monoclonal Anti-TA-MUC1 Antibody PankoMab-GEX". Berlin. 2013-10-16
High-Tech Gründerfonds Management GmbH. (10/16/13). "Press Release: Patient Monitoring at Cellular Level. High-Tech Gründerfonds und Bayern Kapital Lead Investment in Photonics Healthcare". Bonn, Landshut & Garching. 2013-10-16
Pieris AG. (10/16/13). "Press Release: Zydus and Pieris Sign Broad Co-development Alliance for Novel Anticalin Therapeutics. c-Met Antagonist, PRS-110, to Be the Flagship Program". Ahmedabad & Freising. 2013-10-16
Sartorius AG. (10/16/13). "Press Release: Sartorius Stedim Biotech and BD Diagnostics Strengthen Cooperation in the Area of Microbiological Diagnostics. Expansion of Product Portfolio for Microbiological Analyses in the Lab". Göttingen & Baltimore, MD. 2013-10-16
AstraZeneca plc. (10/15/13). "Press Release: AstraZeneca Oncology Portfolio Strengthened as MedImmune Acquisition of Spirogen Boosts Antibody-Drug Conjugate Capability. Additional Investment in and Collaboration with ADC Therapeutics". 2013-10-15
Auven Therapeutics Management L.L.L.P.. (10/15/13). "Press Release: Auven Therapeutics Announces AstraZeneca’s MedImmune Acquires Antibody-Drug Conjugate Company Spirogen and Invests in ADC Therapeutics. Both Auven Therapeutics Portfolio Companies". Laus 2013-10-15
Evotec AG. (10/15/13). "Press Release: Evotec Receives Pre-clinical Milestone as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2013-10-15
Qiagen GmbH. (10/15/13). "Press Release: Qiagen Launches Empowered Genome Community, Invites Citizen Scientists and Researchers to Pool and Collaboratively Interpret Human Genomes". Redwood City, CA & Hilden. 2013-10-15
Horizon Discovery Ltd.. (10/15/13). "Press Release: Horizon Discovery Receives Share of €5.75M ($7.8M) EU FP7 Grant". Cambridge. 2013-10-15
Immatics Biotechnologies GmbH. (10/15/13). "Press Release: Immatics Closes €34 Million Financing to Complete Phase 3 Development of IMA901 for Renal Cancer". Tübingen. 2013-10-15
BioInvent International AB. (10/14/13). "Press Release: BioInvent and Bayer Extend and Broaden Collaboration for the Discovery and Development of Therapeutic Antibodies". Lund. 2013-10-14
Roche. (10/14/13). "Press Release: Roche to Invest 800 Million Swiss Francs in Global Biologic Medicine Manufacturing Network". Basel. 2013-10-14
Biotest AG. (10/11/13). "Press Release: Biotest AG Opens Three Further Plasmapheresis Centers in Hungary and the USA". Dreieich. 2013-10-11
ImmunoGen, Inc.. (10/11/13). "Press Release: ImmunoGen, Inc. Announces New License Agreement". Waltham, MA. 2013-10-11
Wilex AG. (10/10/13). "Press Release: Wilex Publishes 9-Months Financial Report 2013". Munich. 2013-10-10
Cytos Biotechnology AG. (10/10/13). "Press Release: Cytos Biotechnology Plans Financing of up to CHF 17.6 Million. CHF 9 Million of Proposed Capital Increase Already Firmly Committed by Existing Investors". Schlieren. 2013-10-10
Evotec AG. (10/10/13). "Press Release: Evotec and Harvard University to Collaborate on Exploration of Enteroendocrine Signals Affecting Key Metabolic Pathways". Hamburg. 2013-10-10
Mologen AG. (10/10/13). "Press Release: Mologen AG Completed Planning for Clinical Study with MGN1703 in Small Cell Lung Cancer". 2013-10-10
Heptares Therapeutics Ltd.. (10/10/13). "Press Release: Heptares Delivers First Stabilised GPCR (STaR) to MorphoSys for Antibody Discovery". Welwyn Garden City & Boston, MA. 2013-10-10
Bayer AG. (10/9/13). "Press Release: RWTH Aachen University and Bayer Found Research Center. Better Understanding of Disease, Faster Developing of Therapies – a Leading European Center for Computer Based Modeling to Be Created". Aachen. 2013-10-09
Ionicon Analytik GmbH. (10/09/13). "Press Release: PTR-TOF Technology Contributes to CLOUD Experiment at CERN. Scientists Publish New Results Concerning Cloud Formulation in »Nature«". Innsbruck. 2013-10-09
Sartorius AG. (10/9/13). "Pressemitteilung: Veröffentlichung einer Stimmrechtsmitteilung [Sartorius AG – Erbengemeinschaft hält 50,09% der Anteile]". 2013-10-09
Sysmex Corporation. (10/9/13). "Press Release: Sysmex Inostics and Bayer HealthCare Collaborate to Develop Blood-based Companion Diagnostic Tests for Targeted Tumor Therapies". 2013-10-09
Curetis AG. (10/9/13). "Press Release: Curetis Presents New Clinical Validation Data on Its Unyvero P50 Pneumonia / LRT Application". Holzgerlingen. 2013-10-09
Tecan Group Ltd.. (10/9/13). "Press Release: Tecan Maintains Target for Profitability and Adjusts Revenue Guidance for 2013". Männedorf. 2013-10-09
Bayer AG. (10/8/13). "Press Release: Bayer Accelerates Clinical Development of Promising New Drug Candidates [Not intended for U.S. and UK Media]". Leverkusen. 2013-10-08
MorphoSys AG. (10/7/13). "Press Release: MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 (XmAb5574). Extended Treatment Resulted in Higher Overall Response Rate". 2013-10-07
Sartorius Stedim Biotech S.A.. (10/7/13). "Press Release: Sartorius Stedim Biotech Announces Offer to Acquire UK Company TAP Biosystems Group plc. Sartorius Stedim Biotech to Further Expand Its Portfolio of Single-use Fermentors". Aubagne. 2013-10-07
Debiopharm S.A.. (10/7/13). "Press Release: Experimental Therapeutics Centre and Debiopharm Group to Collaborate for the Development of an Epigenetic Innovative Oncology Target". Singapore & Lausanne. 2013-10-07
Sony DADC. (10/7/13). "Press Release: Sony DADC and Schott Develop Glass-plastic Hybrid Cell Imaging Slide". Salzburg & Jena. 2013-10-07
CureVac GmbH. (10/3/13). "Press Release: CureVac to Collaborate with Janssen on Development of mRNA-based Influenza Vaccine". Tübingen. 2013-10-03
Zivak Technologies. (10/3/13). "Press Release: Introduction of SPE9600 Automated 96-Well-Plate SPE System at Medica 2013 Fair". 2013-10-03
next pagenext page 1 2 3 ... 55 56 57 ... 96 97 98  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top